115 related articles for article (PubMed ID: 37792315)
1. An Activatable Prodrug Nanosystem for Ultrasound-Driven Multimodal Tumor Therapy and Metastasis Inhibition.
Zheng J; Ge H; Zhou D; Yao Q; Long S; Sun W; Fan J; Du J; Peng X
Adv Mater; 2023 Nov; 35(47):e2308205. PubMed ID: 37792315
[TBL] [Abstract][Full Text] [Related]
2. Nanomized tumor-microenvironment-active NIR fluorescent prodrug for ensuring synchronous occurrences of drug release and fluorescence tracing.
Li Q; Cao J; Wang Q; Zhang J; Zhu S; Guo Z; Zhu WH
J Mater Chem B; 2019 Mar; 7(9):1503-1509. PubMed ID: 32255021
[TBL] [Abstract][Full Text] [Related]
3. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound (US)-activated redox dyshomeostasis therapy reinforced by immunogenic cell death (ICD) through a mitochondrial targeting liposomal nanosystem.
Ren J; Zhou J; Liu H; Jiao X; Cao Y; Xu Z; Kang Y; Xue P
Theranostics; 2021; 11(19):9470-9491. PubMed ID: 34646381
[No Abstract] [Full Text] [Related]
5. Sequential Ultrasound-Triggered and Hypoxia-Sensitive Nanoprodrug for Cascade Amplification of Sonochemotherapy.
Zhuang F; Ma Q; Dong C; Xiang H; Shen Y; Sun P; Li C; Chen Y; Lu B; Chen Y; Huang B
ACS Nano; 2022 Apr; 16(4):5439-5453. PubMed ID: 35357810
[TBL] [Abstract][Full Text] [Related]
6. Delivery of a system x
Xin H; Huang Y; Tang H; Chen Y; Xia H; Zhang F; Li B; Ping Y
J Mater Chem B; 2021 Sep; 9(35):7172-7181. PubMed ID: 34369535
[TBL] [Abstract][Full Text] [Related]
7. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
[TBL] [Abstract][Full Text] [Related]
8. Redox-Activatable Theranostic Co-Prodrug for Precise Tumor Diagnosis and Selective Combination Chemotherapy.
Qian J; Xu Z; Meng C; Liu Y; Wu H; Wang Y; Yang J; Zheng H; Ran F; Liu GQ; Ling Y
J Med Chem; 2022 Aug; 65(15):10393-10407. PubMed ID: 35877176
[TBL] [Abstract][Full Text] [Related]
9. An ultrasound-activatable platinum prodrug for sono-sensitized chemotherapy.
Liu G; Zhang Y; Yao H; Deng Z; Chen S; Wang Y; Peng W; Sun G; Tse MK; Chen X; Yue J; Peng YK; Wang L; Zhu G
Sci Adv; 2023 Jun; 9(25):eadg5964. PubMed ID: 37343091
[TBL] [Abstract][Full Text] [Related]
10. A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity.
Li Y; Pei Q; Cui B; Zhang H; Han L; Li W; Zhu W; Feng X; Xie Z
J Nanobiotechnology; 2021 Dec; 19(1):441. PubMed ID: 34930288
[TBL] [Abstract][Full Text] [Related]
11. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
[TBL] [Abstract][Full Text] [Related]
12. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific activatable biopolymer nanoparticles stabilized by hydroxyethyl starch prodrug for self-amplified cooperative cancer therapy.
Xiong Y; Wang Z; Wang Q; Deng Q; Chen J; Wei J; Yang X; Yang X; Li Z
Theranostics; 2022; 12(2):944-962. PubMed ID: 34976222
[No Abstract] [Full Text] [Related]
14. An esterase-activatable curcumin prodrug for tumor-targeting therapy.
Liu L; Zhang L; Tao M; Wang M; Dong L; Hai Z
Chem Commun (Camb); 2022 Dec; 58(96):13329-13332. PubMed ID: 36373630
[TBL] [Abstract][Full Text] [Related]
15. Zwitterionic rhodamine-CPT prodrug nanoparticles with GSH/H
Mu X; Huang Z; Feng W; Zhai M; Wang Y; Zhou D; Zhou X
Theranostics; 2023; 13(1):267-277. PubMed ID: 36593965
[No Abstract] [Full Text] [Related]
16. Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance.
Lin YX; Wang Y; An HW; Qi B; Wang J; Wang L; Shi J; Mei L; Wang H
Nano Lett; 2019 May; 19(5):2968-2978. PubMed ID: 30924343
[TBL] [Abstract][Full Text] [Related]
17. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
[TBL] [Abstract][Full Text] [Related]
18. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
19. Reduction of Platinum(IV) Prodrug Hemoglobin Nanoparticles with Deeply Penetrating Ultrasound Radiation for Tumor-Targeted Therapeutically Enhanced Anticancer Therapy.
Liang G; Sadhukhan T; Banerjee S; Tang D; Zhang H; Cui M; Montesdeoca N; Karges J; Xiao H
Angew Chem Int Ed Engl; 2023 May; 62(22):e202301074. PubMed ID: 36961095
[TBL] [Abstract][Full Text] [Related]
20. RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy.
Hao Y; Chen Y; He X; Han R; Yang C; Liu T; Yang Y; Liu Q; Qian Z
Biomaterials; 2023 Feb; 293():121975. PubMed ID: 36580720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
